Tilray | TRLY - 流动资产

股票价格

9.23

每天变化

-0.23 -2.43%

每月一次

-3.75%

每年

1,237.68%

Q2 预测

9.04

金融业

USD

USD 2.1B

现金及等价物

USD 264.83M

USD 164.37M

USD 729.32M

USD 259.32M

USD 640.95M

USD -20.01M

USD 8.37M

USD 2.84K

EPS每股收益

USD -0.41

股本和储备

USD 1.58B

USD 57.47M

债务利息支出

USD 6.7M

USD 12.83M

USD 268.59M

USD 7.16B

USD -44.93M

USD 237.52M

USD -20.01M

普通股股本

USD 116.52M

11.57

USD -39.96M

USD 217.51M

销售和管理费用

USD 24.85M

USD 282.79M

贸易债权人

USD 114.5M

应收帐款人

USD 109.07M

	流动资产	更改		日
Acasti Pharma	USD 17.3M		3.22M	2025-09
Akebia Therapeutics	USD 252.96M		5.38M	2025-12
Alaunos Therapeutics	USD 2.68M		1.05M	2025-09
Aurora Cannabis	CAD 445.84M		22M	2025-12
Avita Medical	AUD 35.49M		760K	2025-12
Canopy Growth	CAD 524.67M		78.85M	2025-12
Cronos Group	USD 944.09M		21.94M	2025-12
Dianthus Therapeutics	USD 409.44M		4.39M	2025-12
Divis Laboratories Ltd	INR 98.43B		2.38B	2025-09
Ionis Pharmaceuticals	USD 2.99B		471.01M	2025-12
IQVIA Holdings	USD 6.25B		270M	2025-12
Knight Therapeutics	CAD 394.84M		5.86M	2025-12
Moderna	USD 6.54B		54M	2025-12
Organigram Holdings	CAD 256.54M		28.35M	2025-12
Organon & Co	USD 4.7B		82M	2025-09
Revvity	USD 2.24B		95.96M	2025-12
Tectonic Therapeutic	USD 257.36M		15.88M	2025-12
Tilray	USD 729.32M		28.18M	2025-09
Viatris	USD 9.79B		162.2M	2025-12
Xeris Pharmaceuticals	USD 240.31M		16.3M	2025-12
Zealand Pharma A/S	15.67B		950.94M	2025-12